Publicaciones en las que colabora con DARÍO ACUÑA CASTROVIEJO (22)

2024

  1. Changes in Cortisol and in Oxidative/Nitrosative Stress Indicators after ADHD Treatment

    Antioxidants, Vol. 13, Núm. 1

2017

  1. Melatonin treatment reduces oxidative damage and normalizes plasma pro-inflammatory cytokines in patients suffering from charcot-marie-tooth neuropathy: A pilot study in three children

    Molecules, Vol. 22, Núm. 10

2011

  1. Melatonin treatment counteracts the hyperoxidative status in erythrocytes of patients suffering from Duchenne muscular dystrophy

    Clinical Biochemistry, Vol. 44, Núm. 10-11, pp. 853-858

2010

  1. Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy

    Journal of Pineal Research, Vol. 48, Núm. 3, pp. 282-289

2007

  1. Melatonin increases following convulsive seizures may be related to its anticonvulsant properties at physiological concentrations

    Neuropediatrics, Vol. 38, Núm. 3, pp. 122-125

2002

  1. Evaluation of plasma levels of melatonin after midazolam or sodium thiopental anesthesia in children

    Journal of Pineal Research, Vol. 32, Núm. 4, pp. 253-256

2001

  1. Characterization of nocturnal ultradian rhythms of melatonin in children with growth hormone-dependent and independent growth delay

    Journal of Clinical Endocrinology and Metabolism, Vol. 86, Núm. 3, pp. 1181-1187

  2. Effect of propranolol plus exercise on melatonin and growth hormone levels in children with growth delay

    Journal of Pineal Research, Vol. 30, Núm. 2, pp. 75-81

  3. Melatonin and β-endorphin changes in children sensitized to olive and grass pollen after treatment with specific immunotherapy

    International Archives of Allergy and Immunology, Vol. 126, Núm. 1, pp. 91-96

2000

  1. Effect of clonidine on plasma ACTH, cortisol and melatonin in children

    Journal of Pineal Research, Vol. 29, Núm. 1, pp. 48-53

1998

  1. Comparison between tryptophan methoxyindole and kynurenine metabolic pathways in normal and preterm neonates and in neonates with acute fetal distress

    European Journal of Endocrinology, Vol. 139, Núm. 1, pp. 89-95

  2. Melatonin's role as an anticonvulsant and neuronal protector: Experimental and clinical evidence

    Journal of Child Neurology, Vol. 13, Núm. 10, pp. 501-509

1997

  1. Efecto de la melatonina como anticonvulsivante y protector neuronal

    Revista de Neurologia, Vol. 25, Núm. 144, pp. 1229-1234

  2. Relationships between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures

    Clinical Endocrinology, Vol. 47, Núm. 6, pp. 667-677

  3. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: Two years' experience

    Journal of Pineal Research, Vol. 23, Núm. 2, pp. 97-105

1996

  1. 5-Methoxytryptophol and melatonin in children: Differences due to age and sex

    Journal of Pineal Research, Vol. 21, Núm. 2, pp. 73-79

  2. Pineal response after pyridoxine test in children

    Journal of Neural Transmission, Vol. 103, Núm. 7, pp. 833-842

1994

  1. Day-night variations in melatonin secretion by the pineal gland during febrile and epileptic convulsions in children

    Psychiatry Research, Vol. 52, Núm. 3, pp. 273-283

  2. Effects of febrile and epileptic convulsions on daily variations in plasma melatonin concentration in children

    Journal of Pineal Research, Vol. 16, Núm. 1, pp. 1-9

1993

  1. Absence of plasma melatonin circadian rhythm during the first 72 hours of life in human infants

    Journal of Clinical Endocrinology and Metabolism, Vol. 77, Núm. 3, pp. 699-703